Evaluation reveals CQ3196 shows 62.3% tumor growth inhibition in gastric cancer models, suggesting strong RIOK2 inhibition potential.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: